<SEC-DOCUMENT>0001144204-12-062650.txt : 20121114
<SEC-HEADER>0001144204-12-062650.hdr.sgml : 20121114
<ACCEPTANCE-DATETIME>20121114164220
ACCESSION NUMBER:		0001144204-12-062650
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20121113
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121114
DATE AS OF CHANGE:		20121114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		121205346

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v328368_8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report (Date of earliest event
reported) November 13, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEDIFAST, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><U>&nbsp;Delaware</U></TD>
    <TD STYLE="width: 34%; font-weight: bold; text-align: center"><U>000-23016</U></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><U>13-3714405</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center">(State or other jurisdiction</TD>
    <TD STYLE="font-weight: bold; text-align: center">(Commission File Number)</TD>
    <TD STYLE="font-weight: bold; text-align: center">(IRS Employer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;of incorporation or organization)</TD>
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">Ident. No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold; text-align: center"><U>&nbsp;11445 Cronhill Drive, Owing Mills, Maryland</U></TD>
    <TD STYLE="width: 50%; font-weight: bold; text-align: center"><U>21117</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;(Address of principal executive offices)</TD>
    <TD STYLE="font-weight: bold; text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>Registrant's telephone number, including
area code <U>(410)-581-8042</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-indent: -45pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 45pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Item 5.02 Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) On November 13,
2012, Brendan N. Connors notified Medifast, Inc. (the &ldquo;Company&rdquo;) of his resignation as Chief Financial Officer. Edward
Powers, who has served as the Company&rsquo;s Senior Corporate Controller since 2011, was appointed acting Chief Financial Officer
effective November 13, 2012. The Company intends to conduct a national search for the CFO position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A press release issued
by the Company in connection with Mr. Connor&rsquo;s resignation is furnished herewith as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"><B>Item
9.01</B>&#9;<B>Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1.5in; text-align: left"><U>Exhibit No</U>.</TD><TD STYLE="text-align: justify"><U>Description</U></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1.5in">99.1</TD><TD STYLE="text-align: justify">Press Release issued by Medifast, Inc. on November 13, 2012.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 50%; text-indent: 0in">MEDIFAST, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Dated: November 14, 2012</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">/s/ Edward Powers</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Edward Powers</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">Acting Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v328368_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Medifast, Inc. Announces Executive Management
Change</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OWINGS MILLS, Md., November 13, 2012 &ndash;
Medifast, Inc. (NYSE: MED), leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss
products and programs, today announced that the Company&rsquo;s Chief Financial Officer, Brendan Connors, will resign to pursue
other interests, effective immediately. Chairman and Chief Executive Officer, Michael C. MacDonald has named Edward J. Powers,
as interim Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;On
behalf of our employees and the Board we would like to thank Brendan for his contributions to the growth of Medifast over the last
seven years,&rdquo; commented Mr. MacDonald. &ldquo;He is leaving Medifast with a strong balance sheet and a robust Finance team
focused on optimizing our overall cost structure to further leverage our sales momentum, improve our margins and deliver increased
earnings results, while continuing to focus on enhancing the customer experience in each of our sales channels - Take Shape for
Life, Medifast Direct, and Medifast Weight Control Center and Wholesale Physicians. We wish him the best of luck in his future
endeavors.&quot;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Powers joined Medifast as Senior Controller
in 2011 with over 30 years of finance and accounting experience. Most recently, Mr. Powers was Global Controller, Construction
Group at Stanley Black &amp; Decker, Inc. (NYSE: SWK) from 2010 to 2011. While at Stanley Black &amp; Decker, Inc., Mr. Powers
also was Director of Finance, Global Product Development from 2009 to 2010 and Director of Finance, Business Planning and Analysis,
Industrial Products Group from 2006 to 2009. Prior to joining Stanley Black &amp; Decker, Inc., Mr. Powers was held various roles
at DeWalt including Director of Finance, Marketing Division from 2000 to 2005, Director of Finance, Business Development from 2000
to 2005, Director of Finance, Latin American Group from 1998 to 1999 and Assistant Corporate Controller from 1993 to 1998. Mr.
Powers also worked for the international accounting firm Coopers &amp; Lybrand for 13 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has engaged an executive recruiting
firm to conduct a search for a new chief financial officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Medifast</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Medifast (NYSE: MED) is the leading easy-to-use, clinically
proven, portion-controlled weight-loss program. The company sells its products and programs via four unique distribution channels:
1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers,
and 4) a national network of physicians. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information,
log onto www.MedifastNow.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please Note: This release contains &quot;forward-looking statements&quot;
within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934,
as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified
by use of phrases or terminology such as &quot;intend&quot; or other similar words or the negative of such terminology. Similarly,
descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking
statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities
and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties,
and other factors. Some of these factors include, among others, Medifast's ability to attract and retain independent Health Coaches
and customers, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers,
increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and
new channels of distribution. Although Medifast believes that the expectations, statements, and assumptions reflected in these
forward- looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual
Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of
this release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact: </B><BR>
Katie Turner (646) 277-1228 <FONT STYLE="color: Blue"><U>Katie.turner@icrinc.com</U></FONT></P>

<P STYLE="color: #000033; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: #000033; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media Contact:</B><BR>
Alecia Pulman (203) 682-8224 <FONT STYLE="color: Blue"><U>apulman@icrinc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``Z`0$#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#T'7?%7B?P
MY^\U*W\/06S.5CGDN9U5O3.(R%/L36&?BU=#_E]\*#W%[.?_`&E7K$D:2H4D
M170]589!K@_$?@B^=Y[[2]8N$CQN^Q"QMYSGN$+@?D35)QZB.:E^+%X[X76]
M`C(Y*P65U.,>[?+@?05S/Q'\2W7B2QTJX-S$J1;E>&WF)BE8\B5"<$C@@AL,
MAZCD$Q:Q;RR01Q:]XC?2;68;XK6?3P)Y`"1O>.$`(N0<!F)XS7/WFA-#IK7.
MEZQ::I8?:(XW\C<C)(V0FZ-P",X(!&16J2W$V>GVWQ$OM&T/3;%K[2_,AMU6
M2[U!Y7:X(')1(P6V#IO;&[&0".:MP_%:Z91EO#,W^TNJM%G\'CR*\H.FQ6=^
M\M[XJL;?4HY#N$:RSL''!RRJ5..AP2.U=EH6CZMKEU%;1OIXD>,2K<IH,$UN
MZ$D!Q+A<="-I`8$$8I.*"YU8^*EP2`+?P\2>@&O)D_\`CE=IH-_KE^))-5TN
MUL8MH,7E7?G,^>Y^48%5?#OA"VT:W5KO[)>WH8-YRV,4(0_[`5>/Q)-8VH_%
MSP_I.H3V%]:ZI#<P-MDC:W'!_P"^N01R#6;UTBAG>T5@^%O%VE>+[.:YTMI=
ML$GER),FUE.,CCTK>J6K#"BN/\2?$KP_X6U7^S;\W3W(C$C""+<%!Z9.1SQ3
M-`^)FC>)=473]+M-2EF(W,3``L:_WF.[@4^5VN%SLZ***D`HHHH`****`"BB
ML'5_&OAO0KY;+4]7M[>Y(!\MLDJ#T+8!V_CBFE<#>HIL<B2QK)&ZNC@,K*<@
M@]"#3J0!1110`4444`%%%%`!1110`4444`%%%%`!1110!POCGPIY]Q_PE5CJ
M_P#96H6-LPDF>(2QR1#)(93^/K]*\KO[OQ7J7A*&]N-'TVVTZXO8'2YBMU@D
MGDW80D`\C)ZX^E?0][9P:A8SV=U&)()XVCD0]U(P17SWJUOKEI!J&BZ=J;W&
M@:5JL%K$MX%+I,6&T#`SM#'V!';M6L'<3-@1^*]1\5?\(UJO]G>')-11W,MG
M8(3<CJP#@G)(SW%>PZ!HEKX=T.UTFRW>1;)M4N<LQ)R2?<DDUY]X`TZ\U?Q?
MJFI^)KV6[US1I?LR1C;Y$0=?O)CN1GL,?7IZG4S?0$%?-'Q8G6?XD:EM(Q&L
M49^H0'^M?2]>$>#;&+Q;\3?%4\P#020W*9(S@.VQ?_'0:=/2[!D?P/U7[-XF
MOM,=L)>6^]!ZO&?_`(EC^5>\331V\$D\SA(HU+NQZ``9)KY2\-W\GAGQG874
MQ*M9W?ES_P"[DH_Z$U[;\8O$']D^#&LHGQ/J3>2,=?+'+G\L#_@5.<;R$GH>
M%>(]:?Q#XCO]5?(^TRED4_PH.%'_`'R!7JGP%A3RM=GP/,WPIGVPQ_K6!XQ\
M,CP[\+?#J21A;N6Z,UP<<AGC)V_@`!^%;WP%D^37HN^Z!OT<5<G>&@+<]EHK
MR?XF_$VZT2^;0M#94NT4&YNB`WEY&0J@\;L<DGID?A!X3^']SXJ\.1:UX@\0
M:PUS>*9(5CNB!&O\).<Y)ZXX&*RY-+L=SU^BOG&'Q?XE^'GBJZTV;49=0M;2
M;RY(+ARRR)U!4G)4X(/7&?6O5_%?Q'L-!\*V6K606ZFU%`UE$3@$$`EFQT`R
M,^_%#@T%SMZ\L^,U_JFCVFEWNF:K>V9DD:&1()2JL,;@>._!_.N,\/W_`(U^
M(_B!K7^WKJUMT'F7#P,8TB3.``JXR3VR?7TJW\5?"L?AS2=*=-6U6^:29D;[
M;<F11\N<J,<&JC&TM0OH=/\`!35=1U6RUI]1O[F[9)HPIGE+[05/3/2JOB_X
M/ZAKOBFZU2PU.VCANW#R+<*Q:,X`.,=1Q[4GP%_Y!^N?]=XO_037*>/_`!)X
MDT7QIJFG6OB'45MHW#1J)<;0RAL<>F<4[/G=A=#WS1=,31=$LM,CD:5+6%80
M[]6VC&:XOXH^/)_"=G;V6F%/[3NP6#L-PAC'&['<D\#/H?2NJ\,RS7?@_299
M9Y&GEL8F:5CN8L4&6.>ISSS7SE\0R8_'.JQM?7-[Y+A#-<$%LA02.```"2``
M!4PC>6HV]#T7X=^%I/%^F2:_XIOK[4!+(R6\$ERZH`O!8A2.^0!T&*[WPUX/
MM?#%]J,MI<W+P73*8H)9F=8%`Y"Y)ZDD_D*QO!?@IM-T31YVUO6%*Q).]FMP
M!!N8;BNW;G&3TS5H:7XKUK5[][S6I=*TA)V2U@LXD$TB#C<SL#M!.<8YQZ42
M=V]01V5%>3?$#P?>Z-X?N-<TSQ/KGF6N&ECN+UF#J2!P1C!&<U2^$7C?6-2U
MN71-5O)+R-H&EADE.70J1D;NI!![^E+DTN@N>S45XS\3OB5J>GZU-H.B3?91
M``+BY4`N6(SM7/0`$<]<UK^`M)TK7]!M[VX\1ZI?:I(F;A?[3E1H7[J$5AC'
MJ>O6CDLKL+GI]<3\1_&]QX+TZT>TM(I[B[=D0RL0L>!G)`Z]?45KZ-HVJZ3J
MT_F:U<7^E21#RHKO#2PR9_O@`LI'KR/>O)?C;826NMZ=<R7]S<"XCDVQ2E=D
M(!7A``,9SSG)XZT02<K`]COOA1K6HZ_X7N[_`%2Y:XN'OI!N/`4;4PJ@<`#T
MKNZ\7^%'A?\`M?PK<78US6;`F[>,QV-R(T.%7DC!YYZ^PKV6*/R84CW.^Q0N
MYSECCN3W-$TK@A]%%%0,****`"O`?BQ:06GCB::=9;1+F*!XVM0/W^&Q([\_
M>48V\<X%>_5XU\:(C;:MIE\KRVXEC$;31C>7*2JP!7MMR6![GBKI_$)G5_"6
MR%MX)280*@N;B65)C_K)X]V%>3D_-CM7=5SO@2T-EX(TF)HO+=H!(PW[MS.2
MQ;/OG..V<5T53+<:,_7=172-`U#4'8*+:W>3)]0IQ^M>8_`>R(T[6=1<9>69
M(0W^ZNX_J]6OBQKE]J&E'P_HVFZC<^:X-W-':2%`JG.P''))`SCC`]Z/A#>M
MI&AS:1J6GW]G<M=&2-I;20)(&"C[VW`(([U:5H"ZGFWQ/TK^S/B!JD8&([DB
MY3_@8Y_\>#5JZ#<7GQ)\<:!;WT0^S:9;)YP!)#+'R6/N[;1BNG^-GAV[OKK2
M-1L+.>YE.ZUD6&,N?[R=/^!5TWPP\%/X3T5Y[Y`-4O<-,!SY2C[J9_$D^Y]J
MOF7+<5M3-^.*`^#+-^ZWZ?JCUS/P(GVZWK,&?OVT;X^C$?\`LU;?QBN[G5M/
MM=%TS3K^[DCN/.G>*UD9$VJ0!NQ@D[NWI7(?#0:KX7\7I=7^C:I'9SPM!*XL
MI#LR002`,XR/UI+X+!U.:\<I*GCS7EF!W_;9#SZ$Y7],5[+X0\+R:SX/TFXN
M?%&L/;/:H$MK:5;=$`&-F4&XXQC)/:H/B#\.U\8K'KNB2*FH&,*\<H*+.HZ=
M1E6'3D<CZ5SO@S5_&/@.-]*U'PMJ5YIY<L@AC+-$QZ[2,@@]<9ZT-\T=`ZGI
M=E\/_"UC+YR:-;S3'DRW.9W8^I+D\UY%\:P8_%]C;I&L=O%8+Y2*,*,NV<#\
M!7H,_C+Q/K,D-GH?A/4K+SG57OM0C"+"I/S,%SR0/_U&G_$OP%)XNL+>YL'1
M=3LP0@D.!,AZJ3V.1D'Z^M3%V>HV8OP(2(:%J\BX\YKM5?UVA!C^;4SX\?\`
M('T;_KZ?_P!`KG/`\?C'P'K4YE\+ZE<V5P`EQ%#'N.1T=2,@D9/U!K3^)MUK
M'C&'3[;3?"NN)';.TCO/:%221@``9]^:JWOW%T+GP%_Y!^N?]=XO_037"?%;
M_DI&K_\`;+_T4M>A?!C3M3T;^U[34]*O;-IC'+&\\#*K``@C)[\BN-^('A_7
M]:\<ZK?66@:G);.ZHD@MFPX5`N1QTR#33]]AT/;O"3K'X(T5V.%73X22>PV"
MOF=!)XF\9`'E]2U#]'D_P->[3ZG-I7P4:>>VFM;J#3!;-%.A1EDVB,<'W.17
ME7PCTEM1\?6DNPF&P1KASV!QM7]3^E*&EV#/I`F."$DE4CC7)).`H%>0ZQ\7
M=0U76H]&\'6<3O-*(8KJX&=Y/=5[+WR>W:O4-?T^75?#NHZ?#)Y<MS;21(YZ
M`LI`S[5\TZ?IWB;PEXGM+D:)>?;;27<L?D,ZOU!`*C!!!/(J8),;/3?B!H6H
M:=\/KR\UCQ+J%_>L8U,:LL5N6+C($:CD=>I[9KC/@W_R4.+_`*]9O_9:[+Q/
MI_B_X@>&9IKC2SI%O:+Y\%@6\R:[D'KTV@#.!C))KG/AAH6N:+XZM;K4-#U&
M"W>*2$RO;L%0L."3C@<8_&K7PL74ZKQ_\*)_$&K2ZSHUU%'<S`>=;SY"NP&-
MRL,X.`."*\LU7P)XJ\/AKFZTFX2.(;C<6[!PH]<J<C\<5[E_PD^M:+K^I6^L
M:)?S:29MUG?6D/G;4('RNJY;`.<'%1ZK\4-&M[5UTZUU#4;QE(CMX[*5<MVW
M%E&!4QE):`TCR?P7\1]?TG6K*WNK^:^T^:5(I(KAMY4,<95CR",YQG%=+\>?
M^/[0O^N<W\TJG\/?ACJMSK=MK&N6ILK.WD$R02##RN#E?E_A4'GGGC%=/\9?
M"^I:W8Z=?Z9;/=-9EUEBC&7VMCY@.^"O0>M4VN=6#H3_``0_Y$:X_P"O^3_T
M%*]*KP3X;^*-:\+076EMX8U2^BFD\U%A@961\`$'(Q@X'TKT^^\67VE:3ITU
M]I.V_O,LUL)>(1D<%L')&Y<X&.IX`J)Q=QHZRBN!_P"%KZ3_`,^-Y_XY_C14
M\K"YWU%%%2,*\X^+VCZCJ&DZ=<Z3:S3W<-TL9$6"0K$$9'^^J<]N_%>CT4T[
M.X%73;./3M+M+*)2L=O"D2@G)```Z]ZM444@"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@#S3XNS7>I6>F^%M*A:XO[^;S6B3M&G=O1=Q')]#71>!/!EO
MX-T3[.&66^G(>ZG`X9NRC_9';\3WK6TZ&+^TM3N/+3SC,(S)M&XJ$4A<]<`D
M\>YK3JF]+""BBBI&%%%%`!1110`4444`%5[NPM+^-8[RVAN$4Y"RH&`/XU8H
3H`A^QVO_`#[0_P#?`HJ:B@#_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
